AAV-CAG-GFP (AAV Serotype PHP.eB)

Product Category: Pre-made recombinant AAV; AAV-CAG-GFP; AAV-CBA-GFP, AAV(PHP.eB)-CAG-GFP; AAV(PHP.eB)-CBA-GFP
Description: AAV(PHP.eB)-CAG-GFP is a pre-packaged rAAV in serotype PHP.eB (with capsid from AAV serotype PHP.eB and 2xITR from AAV serotype 2) which over-expresses EGFP under CAG (also known as CBA) promoter. CAG promoter is a combination of the cytomegalovirus (CMV) early enhancer element and chicken beta-actin promoter for high levels of gene expression in mammalian expression vectors. Compared with rAAV serotype PHP.B, rAAV in serotype PHP.eB is able to penetrate brain-blood barrier (BBB) and infect CNS via tail vein I.V. with 5 times better transduction efficiency. Ready to use format.
Titer: >1E+13 VG/mL
Size: 30 µL (Std Pack)
Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 30 µL, 10 µL |
Customers who bought this product also purchased…
-
SL101472AAV-CAG-GCaMP6f (AAV Serotype 1)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100816AAV-CAG-GFP (AAV Serotype 2)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100823AAV-CAG-GFP (AAV Serotype 5)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL116068AAV-CAG-Cre-GFP (AAV Serotype PHP.eB)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100893AAV-CAG-Cre-GFP (AAV Serotype 9)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100819AAV-GFP (AAV Serotype 5)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL116015AAV-CAG-Cre (AAV Serotype PHP.eB)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.


